Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Government refuses to acknowledge anxiety as patient harm

Pharmacy minister Earl Howe told C+D that the government deals with stock shortages 'very effectively' and that their effect on patients should not be 'exaggerated'

EXCLUSIVE

The government has rejected calls to widen the definition of patient harm to reflect anxiety caused by stock shortages.

Patient harm should remain restricted to clinical outcomes and not include the distress experienced when patients were unable to access their medicines, pharmacy minister Earl Howe told C+D in an exclusive interview on Friday (August 1).
 
The government dealt with shortages "very effectively" and their effect on patients should not be "exaggerated", Earl Howe said at a ground-cutting ceremony for the new Jhoots Pharmacy headquarters in Walsall.
 
 

The minister said he did "not accept" the call by the all-party pharmacy group (APPG) last month (July 23) for the government to revise its "narrow" view of patient harm and do more to address stock shortages. 

The number of shortages was "very few" in the context of the "thousands" of drugs dispensed in the NHS every day, Earl Howe said.
 
"While distress and worry are regrettable and should be avoided, if a pharmacy doesn't have a particular medicine it will normally be there in a few hours. There are tried and tested processes for pharmacists to access medicines on an emergency basis direct from the manufacturer, and that is what usually happens if there is a delay in delivery," he said.
 
"No-one wants to see patients inconvenienced, but I think the definition of harm is one that we need to stick to," he added.
 
Following a round table meeting with pharmacy bodies, manufacturers, wholesalers and the Department of Health (DH) last month, APPG chair Kevin Barron MP warned that the DH's supply forum was failing to address shortages of generic medicines, which could be "disastrous" for patients.
 

In May, Earl Howe ignored C+D's call for urgent action to resolve medicines shortages, despite  evidence from readers of patient harm in three-quarters of cases. He also failed to retract his statement that the current approach to shortages was "working well".

 
 
What do you think of Earl Howe's comments? 
 
We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD017192

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel